605 DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AGED 1-11 YEARS IN THE PHASE 3 EOE KIDS TRIAL
Mirna Chehade(New York Proton Center), Arsalan Shabbir(Northwestern University), Jennifer Maloney(Regeneron (United States)), Bethany Beazley(Regeneron (United States)), Jonathan M. Spergel(Children's Hospital of Philadelphia), Eric Mortensen(Regeneron (United States)), Evan S. Dellon(University of North Carolina at Chapel Hill), Lila Glotfelty(Icahn School of Medicine at Mount Sinai), Marc E. Rothenberg(Cincinnati Children's Hospital Medical Center), Ruiqi Liu(Sun Yat-sen University), Leda Mannent(Sanofi (France)), Elizabeth Laws(Sanofi (United States))
Cited by 2
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
|Gastroenterology|2015|996